SURAKSHA
Suraksha Diagnostic Limited (SURAKSHA) Stock Analysis
Suraksha Diagnostic Limited operates pathology laboratories and diagnostic centers offering imaging and testing services. It provides clinical diagnostics to patients and hospitals with growing chain footprint. The company competes in organized diagnostics in eastern and central India. It is listed on Indian stock exchanges.
Healthcare › Diagnostics & Research
₹306.70
-3.02% 1W | +5.90% 52W
Market Cap
1.6k CR
P/E Ratio
44.6
52W High
₹360
52W Low
₹224.1
Div. Yield
0.16%
Beta
–
50 DMA
₹322.3
200 DMA
₹284.4
Profit Margin
11%
Inst. Own.
21.5%
📊 CONSOLIDATION
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 60 | 52 | 55 | 61 | 67 | 60 | 65 | 73 | 79 | 78 | 81 | 88 |
| Expenses | 39 | 36 | 36 | 40 | 44 | 41 | 46 | 49 | 55 | 55 | 57 | 57 |
| Operating Profit | 21 | 15 | 19 | 21 | 23 | 18 | 19 | 24 | 24 | 23 | 24 | 30 |
| OPM % | 35% | 30% | 35% | 34% | 35% | 31% | 29% | 33% | 31% | 30% | 30% | 35% |
| Other Income | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 |
| Depreciation | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 10 | 11 | 11 | 11 |
| Profit before tax | 11 | 6 | 9 | 11 | 14 | 8 | 9 | 12 | 12 | 10 | 10 | 17 |
| Tax % | 24% | 27% | 32% | 27% | 26% | 26% | 22% | 26% | 27% | 28% | 38% | 22% |
| Net Profit | 8 | 5 | 6 | 8 | 10 | 6 | 7 | 9 | 9 | 7 | 6 | 13 |
| EPS in Rs | 1.95 | 1.08 | 1.51 | 1.84 | 2.40 | 1.18 | 1.42 | 1.80 | 1.73 | 1.44 | 1.21 | 2.50 |
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 158 | 140 | 223 | 190 | 219 | 252 | 310 | 325 |
| Expenses | 123 | 115 | 174 | 143 | 146 | 170 | 214 | 223 |
| Operating Profit | 34 | 25 | 49 | 47 | 73 | 82 | 96 | 102 |
| OPM % | 22% | 18% | 22% | 25% | 33% | 33% | 31% | 31% |
| Other Income | 2 | -1 | 1 | 1 | 1 | 4 | 3 | 3 |
| Interest | 2 | 2 | 2 | 10 | 10 | 9 | 13 | 14 |
| Depreciation | 13 | 16 | 15 | 32 | 33 | 35 | 41 | 43 |
| Profit before tax | 21 | 6 | 33 | 7 | 31 | 41 | 45 | 49 |
| Tax % | 28% | -1% | 28% | 10% | 26% | 25% | 30% | |
| Net Profit | 15 | 6 | 24 | 6 | 23 | 31 | 31 | 35 |
| EPS in Rs | 3.53 | 1.49 | 5.51 | 1.51 | 5.48 | 6.11 | 6.18 | 6.88 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 1% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 18.0% | 17.0% | – |
| Profit CAGR | 62.0% | 32.0% | – |
Shareholding Pattern
Promoters48.98%
FIIs13.73%
DIIs21.98%
Public15.30%
Promoters49.00%
FIIs13.46%
DIIs22.57%
Public14.98%
Promoters49.10%
FIIs13.46%
DIIs23.14%
Public14.31%
Promoters49.10%
FIIs13.47%
DIIs23.22%
Public14.20%
Promoters49.10%
FIIs13.98%
DIIs21.56%
Public15.37%
Promoters48.78%
FIIs14.46%
DIIs22.05%
Public14.71%
Promoters49.10%
FIIs13.46%
DIIs23.14%
Public14.31%
Promoters49.10%
FIIs13.98%
DIIs21.56%
Public15.37%
SURAKSHA
Holdings Analysis
Key strengths & risk signals
78
Overall
86
Fundamental
71
Technical
Risks (4)
NEGLIGIBLE DIVIDEND! 0.16% yield - little to no income.
RECOVERY MODE! Current price (306.7) above 200-day but below 50-day.
POSITIVE YEAR! Stock gained 5.9% in the last year.
WEAK MOMENTUM! Limited price growth - -3.0% (1 week), -6.2% (1 month), 18.4% (3 months).
Strengths (4)
UNDERVALUED! PEG of 0.63 indicates stock is cheap relative to growth.
BULLISH TREND! 50-day average (322.3) is above 200-day average (284.4) - positive signal.
BULLISH SENTIMENT! In last 30 days: 16 up days, 14 down days. Avg volume on up days: 95,678 vs down days: 56,771. Ratio: 1.69x
APPROACHING OVERSOLD! RSI at 39.4 - watch for reversal.
Fundamental & Technical Analysis
78Overall
86Fundamental
71Technical
Fundamental Breakdown
Growth Quality
28/30
Revenue CAGR: 17.7% (VERY GOOD, 13/15). Profit CAGR: 70.3% (EXCELLENT, 15/15).
Profit Margin
5/10
DECENT EFFICIENCY! 11.0% profit margin - acceptable profitability.
PEG Valuation
10/10
UNDERVALUED! PEG of 0.63 indicates stock is cheap relative to growth.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.16% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 15.39% public ownership - strong promoter/institutional control.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (322.3) is above 200-day average (284.4) - positive signal.
Price Position
2/10
RECOVERY MODE! Current price (306.7) above 200-day but below 50-day.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
4/10
POSITIVE YEAR! Stock gained 5.9% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 16 up days, 14 down days. Avg volume on up days: 95,678 vs down days: 56,771. Ratio: 1.69x
RSI
4/5
APPROACHING OVERSOLD! RSI at 39.4 - watch for reversal.
52W Range
4/5
UPPER HALF! Trading at 60.8% of 52W range - positive territory.
Momentum
2/5
WEAK MOMENTUM! Limited price growth - -3.0% (1 week), -6.2% (1 month), 18.4% (3 months).
Beta
3/5
MARKET ALIGNED! Beta of 1.00 - moves with the market.
SURAKSHA
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q4FY262026-05-27 | Concall PDF | |
| Q3FY262026-02-12 | Concall PDF | |
| Q2FY262025-11-14 | Concall PDF |
Peer Comparison
Healthcare · Diagnostics & Research · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SURAKSHA | ₹306.70 | 44.6 | 11.0% | 17.7% | 70.3% | +5.9% | 78 | BREAKDOWN | +38.3% | +106.3% | +20.7% | +7.6% |
| KRSNAA | ₹533.30 | 18 | 11.6% | 16.6% | 17.8% | -32.4% | 61 | APPROACHING SUPPORT | -19.0% | -60.2% | +22.0% | +22.3% |
| VIMTALABS | ₹522.50 | 29.6 | 18.9% | 8.9% | 17.2% | -21.8% | 57 | BREAKDOWN | +11.1% | -0.5% | +11.8% | -0.1% |
| THYROCARE | ₹485.20 | 44 | 20.1% | 16.7% | 36.2% | +17.6% | 87 | BREAKDOWN | +34.2% | +10.8% | +24.4% | +7.1% |
| METROPOLIS | ₹530.40 | 54.6 | 11.8% | 12.8% | 10.0% | +7.9% | 67 | BREAKDOWN | +25.7% | +11.4% | +16.6% | +6.0% |
| VIJAYA | ₹1,381.70 | 76 | 21.9% | 21.0% | 26.9% | +41.3% | 74 | BREAKDOWN | +37.6% | +10.9% | +22.8% | +5.3% |
| SYNGENE | ₹386.10 | 70.3 | 6.1% | 5.4% | -12.0% | -40.0% | 57 | BOUNCE FROM SUPPORT | -110.4% | -106.1% | -15.8% | -29.0% |
| SAILIFE | ₹1,389.40 | 82.1 | 16.1% | 21.3% | 226.9% | +60.0% | 70 | BREAKDOWN | +21.2% | -29.7% | +11.7% | -7.9% |
Data from TradeAlone · Updated daily
